WASHINGTON, D.C. (March 31, 2019)—Monday evening, the Centers for Medicare & Medicaid Services (CMS) released an Interim Final Rule (IFR) addressing a range of healthcare issues related to the novel coronavirus (COVID-19) outbreak. AAHomecare performed an initial analysis of the IFR that indicates that priority policy recommendations from the HME industry have been included, except for the delay of competitive bidding.

WASHINGTON, D.C. (October 3, 2019)—The Centers for Medicare & Medicaid (CMS) announced that the next state to participate in the Review Choice Demonstration (RCD) is Texas and it will begin on Dec. 2, 2019. CMS also indicated that implementation of RCD in the remaining states of North Carolina and Florida is expected to begin on March 30, 2020, as CMS is pausing implementation to allow for the transition to PDGM which begins on Jan. 1, 2020.

WASHINGTON, D.C. (June 18, 2019)—Performant, the Recovery Audit Contractor (RAC), has received approval to audit blood glucose test or reagent strips (A4253) as of June 14, 2019. This is a national complex review and the description of the review states: “The quantity of glucose test strips (A4353) that are covered depends upon the usual medical needs of the diabetic patient.

NEW BEDFORD, Mass. (February 14, 2019)—On February 12th, the Home Medical Equipment & Services Association of New England (HOMES) was invited by Health & Human Services (HHS) Secretary Alex Azar and Region 1 director John McGough to the CMS and HHS Region 1 office to listen and understand issues related to Medicare policies and home medical equipment.

WASHINGTON, D.C. (October 4, 2018)—In June 2018, the Office of Inspector General for the Department of Health & Human Services reported that most Medicare claims for replacement positive airway pressure device supplies did not comply with Medicare requirements. A sample of 110 claims were reviewed, and 86 did not meet the requirements, totaling $13,414 in overpayments.